May 2, 2017 8:05 am EDT Abeona Therapeutics Provides Update on EB-101 Gene Therapy for Severe Form of Epidermolysis Bullosa from the Society for Investigative Dermatology Conference
Apr 25, 2017 8:05 am EDT Abeona Therapeutics Announces EB-101 Clinical Update to be Presented at the Society for Investigative Dermatology Annual Meeting
Apr 5, 2017 7:43 am EDT Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences
Mar 31, 2017 8:05 am EDT Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights
Mar 8, 2017 8:15 am EST Abeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa
Mar 7, 2017 7:45 am EST Abeona Therapeutics To Present At The Cowen and Company 37th Annual Health Care Conference
Mar 3, 2017 7:44 am EST Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai
